Skip to main content

Here We Go... June is Upon Us

 Ah June, the month I expect big things to happen.

First up: BOT. June 21 is when the FDA result is expected to be announced. And since this is a Friday, we may not receive the news until after trading has ceased for the day. It may have to wait until Monday (the 24th). Will it be a Tradng Halt? Then we will have to wait an extra couple of days.

The result is almost certainly going to be positive and the share price should rise 50-100% from where it is now. 

PLUS, once that risk is completely dealt with, there is a strong chance that Big Pharma will buy BOT, possibly doubling the share price again. And that could happen very quickly indeed.

I reckon that right now is the last realistic chance to get a position in BOT at a good price.

DTR is expecting to do a resource upgrade in the June quarter. And because this is one of 2 reource upgraes they will do this year (after not doing one before, instead simply relying on historical data), I expect the upgrade to be completed in June. I expect a significant increase in the resource, and this should change the share price remarkably - I reckon at least doubling the price.

Again, right now is the time to make sure you secure a position in DTR.

June is on and the End Of the Financial Year is just around the corner. Bring it on!

Labels:

Comments

Post a Comment

Popular posts from this blog

A Couple of Updates

 Well, it's Monday morning and the week has started with a bang. First, PFE announced that there was an unexpected problem with their test drill and they have had to abandon that and go to a new test drill site. A delay, but no real issue apart from that. And the market hated that. Good news for those wanting to buy, not so good for existing holders. IMC released their AGM presentation which indicates that there will be some news in December and then a very busy (and hopefully productive) 2025. Sales are good and continuing to get better and better.
Post a Comment
Read more

2025 - an early start

 Ok., so here we go on my Trump-era goal. Just bought MXR (yes, on the ASX). AAR wants to take them over at 7 cents as a scrip payment (paying in AAR shares instead of cash). The current share price is 6.3 cents. So that should be a quick 10% gain. However... this does look like a lowball offer and may yet be increased. MXR has great assets and AAR already owns almost 20% of MXR. So AAR is committed to a deal and that may just attract other attention. It looks like a no-brainer to start 2025. Yes, there is always some risk, but this one looks pretty good. I have done a bit more research and have some exciting thoughts, including one that looks a little like another WGO (which returned handsomely on a takeover). More news coming as I do more reseach.  Another one that looks good for a quick profit is GES, but as I write this, there are no shares at the right price (.05).
Post a Comment
Read more

Out of 2

 I ahd some bills to pay and these 2 got the chop: PFE - such promise, such disappointmen IMC - I always had some ethical problems with this one.  But there it is. Bills paid, and a little left over to find something new with. 
Post a Comment
Read more